300396 ST迪瑞医疗
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.493-14.5023.3468.28813.794
总资产报酬率 ROA (%)0.285-8.0101.9485.0369.875
投入资产回报率 ROIC (%)0.311-8.9822.2005.79811.230

边际利润分析
销售毛利率 (%)45.34840.57351.66550.99751.989
营业利润率 (%)1.721-36.9256.84214.38623.949
息税前利润/营业总收入 (%)4.506-37.5659.14213.47722.687
净利润/营业总收入 (%)1.857-30.4816.66614.31721.460

收益指标分析
经营活动净收益/利润总额(%)108.85731.13839.16471.34091.606
价值变动净收益/利润总额(%)156.517-6.84433.99421.02210.971
营业外收支净额/利润总额(%)-1.4630.1302.960-0.426-0.255

偿债能力分析
流动比率 (X)1.7361.8021.8291.4892.016
速动比率 (X)1.1421.2071.0270.9911.602
资产负债率 (%)39.72744.56044.93543.38334.409
带息债务/全部投入资本 (%)32.85937.66835.67134.45320.470
股东权益/带息债务 (%)199.382161.534176.230185.468377.620
股东权益/负债合计 (%)151.720124.417122.542130.501190.615
利息保障倍数 (X)1.60463.4944.370-15.893-18.890

营运能力分析
应收账款周转天数 (天)85.729101.926127.725106.76569.913
存货周转天数 (天)444.389559.999570.481358.521188.440